Cairn Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- Cairn Diagnostics's estimated annual revenue is currently $3.6M per year.
- Cairn Diagnostics's estimated revenue per employee is $155,000
Employee Data
- Cairn Diagnostics has 23 Employees.
- Cairn Diagnostics grew their employee count by 5% last year.
Cairn Diagnostics's People
| Name | Title | Email/Phone |
|---|
Cairn Diagnostics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 11 | 0% | N/A | N/A |
#2 | $5M | 32 | 14% | N/A | N/A |
#3 | $3.6M | 23 | 5% | N/A | N/A |
#4 | $1.1M | 7 | -22% | N/A | N/A |
#5 | $1.7M | 11 | 0% | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $6M | 39 | 50% | N/A | N/A |
#8 | $0.9M | 6 | 0% | N/A | N/A |
#9 | $4.8M | 31 | -6% | N/A | N/A |
#10 | $1.9M | 12 | 0% | N/A | N/A |
What Is Cairn Diagnostics?
Cairn Diagnostics is a unique team of scientists, customer support professionals, and operations experts focused on creating cutting edge products and services and a world-class customer experience. Cairn makes the 13C Spirulina Gastric Emptying Breath Test (GEBT) which is a non-radioactive, non-invasive, orally administered test for measurement of the rate of solid phase gastric emptying in adults. The GEBT has been validated against the reference method of gastric scintigraphy. The GEBT utilizes the stable isotope carbon-13, denoted as 13C. The GEBT may be administered in a primary care facility, clinic or tertiary care setting
keywords:N/A
N/A
Total Funding
23
Number of Employees
$3.6M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Franklin
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.3M | 23 | 5% | N/A |
#2 | $2.4M | 23 | -8% | N/A |
#3 | $4.3M | 23 | 5% | N/A |
#4 | $35M | 24 | 20% | N/A |
#5 | $4.1M | 24 | -8% | N/A |